is tirzepatide still available FDA Says Compounded Must Exit the Market FDA says the tirzepatide weight-loss
Description
Why this matters (India lens) * Injectables = device + cold chain + cost * Oral = manufacturing + distribution advantage * Post patent wave crowded market, sharper differentiation needed My take The next winners wont be just best molecule
Some patients report scalp itching or increased flaking (18.92% of users) or facial hair growth (6.93% of cases)
But the pharmaceutical options are also far more potent in terms of weight loss outcomes

Exogenous Nature of Skinny Shots Skinny shots, such as Ozempic, are an exogenous substance, which essentially means it is something not naturally occurring in the body
The consensus
